BCL2 and cancer: We may hypothesize that the lower expression of IL-6 determined in M. U-care–treated mice would be related to a decrease in cancer cell proliferation, in which IL-6 could act on Bcl-2 expression, altering the proliferation/apoptosis balance toward neoplastic cell apoptosis.